Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Steroid rinse inside the tooth: a new way to curb root canal pain?

NCT ID NCT07821359

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 15, 2026 · Last updated Sep 17, 2026 · Updated 2 times

Summary

This trial compares two final rinses used during two-visit root canal treatment for adults with symptomatic irreversible pulpitis, a painful tooth infection. Participants receive either a dexamethasone solution or normal saline as the last rinse inside the root canal. Researchers measure pain with a 0 to 10 scale at 24 hours, 48 hours, and 7 days after treatment to see whether the steroid rinse reduces discomfort.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dexamethasone solution used as a final rinse inside the root canal
What this could lead to
If it helps, dentists could add a steroid rinse to standard root canal care to reduce pain in the days after treatment.
What could go wrong
This is a small single-center study of 72 people, so the results may not hold up in larger or more varied groups. Steroid rinses can also carry risks, and the trial may show no clear difference from saline.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

72 people

The number who actually took part.

Started

Feb 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adults aged 18-65 years. 2. Patients diagnosed with symptomatic irreversible pulpitis in a maxillary or mandibular premolar or molar. 3. Positive response to cold/thermal pulp testing and electric pulp testing. 4. Clinical features consistent with symptomatic irreversible pulpitis, including spontaneous pain and/or pain elicited by thermal stimuli, with clinically evident deep carious involvement or pulpal exposure. 5. Patients indicated for two-visit root canal treatment. 6. Ability to understand and complete the Visual Analogue Scale (VAS) for pain assessment. 7. Absence of active periodontal disease. Exclusion Criteria: 1. Use of analgesics, antibiotics, or anti-inflammatory medications within 24 hours before treatment. 2. History of chronic pain. 3. Evidence of periapical involvement or pathology, including periapical abscess, sinus tract, or periapical cyst. 4. Pulp necrosis. 5. Internal or external root resorption. 6. Unfavourable tooth position, ankylosis, trismus, or significant malposition associated with traumatic occlusion. 7. Immunocompromised status. 8. Known allergy or contraindication to local anaesthetic or dexamethasone. 9. Previous endodontic treatment of the study tooth. 10. Non-restorable teeth or unfavourable crown-to-root ratio. 11. Inability to understand or reliably use the VAS. 12. Inability or unwillingness to attend follow-up assessments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Symptomatic irreversible pulpitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CMH Lahore

    Lahore, 54000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.